HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

miR-185 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer by Targeting KLF7.

Abstract
MicroRNAs (miRNAs) are short endogenous noncoding RNAs that frequently play vital roles in many cancer types. Herein we demonstrated that miR-185 was remarkably downregulated in NSCLC tissues compared with adjacent normal tissues. A lower level of miR-185 was associated with lymph node metastasis. Functional assays showed that upregulation of miR-185 inhibited the proliferation, colony formation, and invasion capacities of NSCLC cells in vitro. Furthermore, we found that miR-185 suppressed the epithelial-mesenchymal transition (EMT) process. Bioinformatics analysis and luciferase reporter gene assays revealed that Kruppel-like factor 7 (KLF7) was the target of miR-185. Overexpression of miR-185 reduced the expression of KLF7 in NSCLC cells. Upregulation of KLF7 partly neutralized the inhibitory effects of miR-185 on the proliferation and invasion of NSCLC. Additionally, we confirmed that miR-185 suppressed the tumor growth of NSCLC A549 cells in vivo. Taken together, these results demonstrate that miR-185 acts as a suppressor by targeting KLF7 in NSCLC.
AuthorsLili Zhao, Yao Zhang, Jiaoxia Liu, Wei Yin, Dan Jin, Dandan Wang, Wei Zhang
JournalOncology research (Oncol Res) Vol. 27 Issue 9 Pg. 1015-1023 (Sep 23 2019) ISSN: 1555-3906 [Electronic] United States
PMID29716672 (Publication Type: Journal Article)
Chemical References
  • KLF7 protein, human
  • Kruppel-Like Transcription Factors
  • MIRN185 microRNA, human
  • MicroRNAs
Topics
  • A549 Cells
  • Animals
  • Carcinoma, Non-Small-Cell Lung (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Movement (physiology)
  • Cell Proliferation (physiology)
  • Down-Regulation
  • Heterografts
  • Humans
  • Kruppel-Like Transcription Factors (genetics, metabolism)
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Mice
  • MicroRNAs (metabolism)
  • Neoplasm Metastasis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: